168 related articles for article (PubMed ID: 26252295)
1. Posttransplant Lymphoproliferative Disorder of the Thorax: CT and FDG-PET Features in a Single Tertiary Referral Center.
Yoon GY; Kim MY; Huh JR; Jo KW; Shim TS
Medicine (Baltimore); 2015 Aug; 94(31):e1274. PubMed ID: 26252295
[TBL] [Abstract][Full Text] [Related]
2. The value of 18F-FDG PET in pediatric patients with post-transplant lymphoproliferative disorder at initial diagnosis.
Vali R; Punnett A; Bajno L; Moineddin R; Shammas A
Pediatr Transplant; 2015 Dec; 19(8):932-9. PubMed ID: 26515450
[TBL] [Abstract][Full Text] [Related]
3. (18)F-FDG PET/CT in the management of patients with post-transplant lymphoproliferative disorder.
Takehana CS; Twist CJ; Mosci C; Quon A; Mittra E; Iagaru A
Nucl Med Commun; 2014 Mar; 35(3):276-81. PubMed ID: 24296883
[TBL] [Abstract][Full Text] [Related]
4. The value of
Si Z; Lu D; Zhai L; Zheng W; Dong C; Sun C; Wang K; Zhang W; Wei X; Zhang Z; Zhao S; Gao W; Shen Z
Pediatr Transplant; 2023 Aug; 27(5):e14501. PubMed ID: 36906739
[TBL] [Abstract][Full Text] [Related]
5. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in diagnosis of post-transplant lymphoproliferative disorder.
Panagiotidis E; Quigley AM; Pencharz D; Ardeshna K; Syed R; Sajjan R; Bomanji J
Leuk Lymphoma; 2014 Mar; 55(3):515-9. PubMed ID: 23772644
[TBL] [Abstract][Full Text] [Related]
6. End-of-Treatment Positron Emission Tomography After Uniform First-Line Therapy of B-Cell Posttransplant Lymphoproliferative Disorder Identifies Patients at Low Risk of Relapse in the Prospective German PTLD Registry.
Zimmermann H; Denecke T; Dreyling MH; Franzius C; Reinke P; Subklewe M; Amthauer H; Kneba M; Riess H; Trappe RU
Transplantation; 2018 May; 102(5):868-875. PubMed ID: 29189632
[TBL] [Abstract][Full Text] [Related]
7.
Montes de Jesus FM; Glaudemans AWJM; Tissing WJ; Dierckx RAJO; Rosati S; Diepstra A; Noordzij W; Kwee TC
J Nucl Med; 2020 Sep; 61(9):1307-1313. PubMed ID: 32005775
[TBL] [Abstract][Full Text] [Related]
8. Clinical usefulness of FDG-PET/CT scan imaging in the management of posttransplant lymphoproliferative disease.
Bianchi E; Pascual M; Nicod M; Delaloye AB; Duchosal MA
Transplantation; 2008 Mar; 85(5):707-12. PubMed ID: 18337664
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of FDG-PET/CT of post-transplant lymphoproliferative disorder and factors affecting diagnostic yield.
Montes de Jesus FM; Kwee TC; Kahle XU; Nijland M; van Meerten T; Huls G; Dierckx RAJO; Rosati S; Diepstra A; van der Bij W; Verschuuren EAM; Glaudemans AWJM; Noordzij W
Eur J Nucl Med Mol Imaging; 2020 Mar; 47(3):529-536. PubMed ID: 31444510
[TBL] [Abstract][Full Text] [Related]
10. Both native and ectopically transplanted hearts shown on FDG PET/CT in a PTLD patient.
Sonoda LI; Sanghera B; Gogbashian A; Lambert J; Wong WL
Clin Nucl Med; 2012 Oct; 37(10):1022-3. PubMed ID: 22899204
[TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography scanning in the setting of post-transplant lymphoproliferative disorders.
Blaes AH; Cioc AM; Froelich JW; Peterson BA; Dunitz JM
Clin Transplant; 2009; 23(6):794-9. PubMed ID: 20447185
[TBL] [Abstract][Full Text] [Related]
12. The accuracy of positron emission tomography in the detection of posttransplant lymphoproliferative disorder.
Dierickx D; Tousseyn T; Requilé A; Verscuren R; Sagaert X; Morscio J; Wlodarska I; Herreman A; Kuypers D; Van Cleemput J; Nevens F; Dupont L; Uyttebroeck A; Pirenne J; De Wolf-Peeters C; Verhoef G; Brepoels L; Gheysens O
Haematologica; 2013 May; 98(5):771-5. PubMed ID: 23065524
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr DNA serology and positron-emission tomography imaging of the head and neck in pediatric transplant recipients.
Sidell D; Venick RS; Shapiro NL
Laryngoscope; 2014 May; 124(5):1236-41. PubMed ID: 24105893
[TBL] [Abstract][Full Text] [Related]
14. 18F-FDG PET for Detection of Primary Tracheobronchial T-/Natural Killer-Cell-Derived Posttransplant Lymphoproliferative Disorder After Lung Transplantation.
Derlin T; Braubach P; Kreipe HH; Hueper K
Clin Nucl Med; 2017 Dec; 42(12):988-989. PubMed ID: 29076909
[TBL] [Abstract][Full Text] [Related]
15. Post transplant lymphoproliferative disease in pediatric solid organ transplant patients: a possible role for [18F]-FDG-PET(/CT) in initial staging and therapy monitoring.
von Falck C; Maecker B; Schirg E; Boerner AR; Knapp WH; Klein C; Galanski M
Eur J Radiol; 2007 Sep; 63(3):427-35. PubMed ID: 17293073
[TBL] [Abstract][Full Text] [Related]
16. FDG-PET/CT in abdominal post-transplant lymphoproliferative disease.
Metser U; Lo G
Br J Radiol; 2016; 89(1057):20150844. PubMed ID: 26544161
[TBL] [Abstract][Full Text] [Related]
17. The usefulness of (18)F-FDG PET/CT for assessing methotrexate-associated lymphoproliferative disorder (MTX-LPD).
Watanabe S; Manabe O; Hirata K; Oyama-Manabe N; Hattori N; Kikuchi Y; Kobayashi K; Toyonaga T; Tamaki N
BMC Cancer; 2016 Aug; 16():635. PubMed ID: 27528380
[TBL] [Abstract][Full Text] [Related]
18. FDG PET/CT Findings of Polymorphic Posttransplant Lymphoproliferative Disorders in a Transplanted Kidney.
Yang Y; Wang W; Kan Y; Liu J; Yang J
Clin Nucl Med; 2018 Jun; 43(6):441-444. PubMed ID: 29485445
[TBL] [Abstract][Full Text] [Related]
19. Posttransplant lymphoproliferative disorder in a lung transplant recipient.
Tamai K; Koyama T; Saga T; Umeoka S; Aoyama A; Hanaoka N; Fukuse T; Wada H; Tachibana M; Togashi K
J Thorac Imaging; 2005 Nov; 20(4):280-3. PubMed ID: 16282905
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography with fluoro-2-deoxy-D-glucose (FDG-PET) in the staging of post transplant lymphoproliferative disorder in lung transplant recipients.
Marom EM; McAdams HP; Butnor KJ; Coleman RE
J Thorac Imaging; 2004 Apr; 19(2):74-8. PubMed ID: 15071322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
